Skip to content

Biodesix, Inc. BDSX Net Investment in Lease

Net Investment in Lease at other companies

NeoGenomics logo
NeoGenomicsNEO
Veracyte logo
VeracyteVCYT
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
Personalis, Inc. logo
Personalis, Inc.PSNL
Guardant Health logo
Guardant HealthGH
Tempus AI, Inc. logo
Tempus AI, Inc.TEM

Other financials

Income statement

See full
Revenue$25.6M+42.3%
Operating income-$6.2M+32.1%
Net income-$7.8M+29.8%
EPS (diluted)-$0.81+46.7%

Balance sheet

See full
Cash & equivalents$25.6M+45.3%
Total debt$71.6M+15.0%
Total equity$9.1M-17.4%
Total assets$94.6M+9.7%

Cash flow

See full
Operating cash flow-$10.2M-18.2%
CapEx$81.0K+9.5%
Free cash flow-$10.2M-18.1%

Valuation

See full
Market cap$233.52M+476%
Enterprise value$279.56M+204%
P/S2.4×+1.9×

Profitability

See full
Operating margin-26%-7.5pp
Net margin-33.3%-9.3pp
FCF margin-26.8%-9.6pp

Returns & leverage

See full
Return on equity-316.5%
Debt / equity7.8×+2.2×
Current ratio2.8×+0.6×

Where this comes from

Reported directly by Biodesix, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biodesix, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biodesix, Inc.'s net investment in lease?
Biodesix, Inc. (BDSX) reported net investment in lease of $3.19M in Q1 2026.
How has Biodesix, Inc.'s net investment in lease changed year-over-year?
Biodesix, Inc.'s net investment in lease increased by 62.5% year-over-year, from $1.96M to $3.19M.
What is the long-term trend for Biodesix, Inc.'s net investment in lease?
Over 4 years (2021 to 2025), Biodesix, Inc.'s net investment in lease has grown at a 23.2% compound annual growth rate (CAGR), from $1.3M to $3M.